Urokinase-Derived Peptide A6

Ref. 3D-UPA-3038-PI

Produktinformation

• Name: Urokinase-Derived Peptide A6
• Synonyme: Ac-Lys-Pro-Ser-Ser-Pro-Pro-Glu-Glu-NH2 A6 Peptide Urokinase Plasminogen Activator (136-143), human Acetyl-Lysyl-Prolyl-Seryl-Sery l-Prolyl-Prolyl-Glutamyl-Glutamic Acid Amide uPA-Derived Peptide A6

Beschreibung

Urokinase-Derived Peptide A6 (UDP-A6) is a protein derived from the urokinase enzyme. It has been shown to have antiproliferative effects on tumour cells and has been studied as a potential treatment for inflammatory diseases such as rheumatoid arthritis. The mechanism of action is not fully understood, but it is thought that UDP-A6 binds to a specific receptor on the surface of cells, called the leukocyte antigen, which causes them to stop proliferating. UDP-A6 has also been shown to bind to the surface glycoprotein of cancer cells and cause them to die.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 910.99 g/mol
• Formel: C₃₉H₆₂N₁₀O₁₅
• Reinheit: Min. 95%